Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07384585 · ClinicalTrials.gov registry record · NA

Feasibility of Light Therapy in the Pediatric Intensive Care Unit (ICU)

A NA study of Circadian Dysregulation and Light Exposure, sponsored by Laura Beth Kalvas.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07384585 is a NA study of Circadian Dysregulation and Light Exposure that is actively recruiting participants, run by Laura Beth Kalvas. The registered enrollment target is 30 participants, below the 68-participant average among 10 other Circadian Dysregulation trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07384585, a NA study of Circadian Dysregulation and Light Exposure, is actively recruiting participants, sponsored by Laura Beth Kalvas.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to understand how easy or difficult it is for critically ill children (4-17 years old) to have light therapy while in the pediatric ICU. Participants will have a light meter at their bedside to measure light levels. Each morning, a light box will be placed at their bedside. Children, family, and staff will be asked to completed feedback surveys regarding the light therapy. Study participation will continue for a maximum of 5 days.

Interventions

  • OTHER Light Therapy

Study Locations (1)

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-03
Est. Completion 2027-01
Phase NA

Sponsor

Laura Beth Kalvas

1 total trials

What the Registry Record Tells You About NCT07384585

The ClinicalTrials.gov registry entry for NCT07384585 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 68-participant average among 10 other Circadian Dysregulation trials with a reported enrollment target (56% lower). The listed sponsor is Laura Beth Kalvas, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Circadian Dysregulation appearing as the primary indexed condition, and to 1 intervention - of which Light Therapy is the first listed.

NCT07384585 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT07384585 about?

NCT07384585 is a clinical study titled "Feasibility of Light Therapy in the Pediatric Intensive Care Unit (ICU)". The goal of this clinical trial is to understand how easy or difficult it is for critically ill children (4-17 years old) to have light therapy while in the pediatric ICU. Participants will have a light meter at their bedside to measure light levels. Each morning, a light box will be placed at their...

What is the current status of trial NCT07384585?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-03. Estimated completion is 2027-01.

What conditions does trial NCT07384585 study?

This clinical trial studies the following conditions: Circadian Dysregulation, Light Exposure, Pediatric Critical Illness.

What interventions are being tested in trial NCT07384585?

The interventions under investigation include: Light Therapy (OTHER).

Who is sponsoring clinical trial NCT07384585?

This trial is sponsored by Laura Beth Kalvas, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07384585 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Circadian Dysregulation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.